Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastrointestinal system function modulation" refers to the therapeutic concept of altering any aspect of GI system physiology, including motility, secretion, absorption, immune response, and barrier function via molecular, cellular, or microbial targets. It is not a discrete target like a receptor or enzyme, but rather an umbrella term describing a range of potential interventions on multiple molecules, such as neurotransmitter receptors (e.g., glutamate receptors, serotonin receptors), immune mediators (e.g., interleukins, tumor necrosis factor-alpha), enzymes (e.g., cytochrome P450s), transporters (e.g., MDR1, MRPs), transcription factors (e.g., aryl hydrocarbon receptor, pregnane X receptor), and interactions with gut microbiota.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal system function modulation.